ProCE Banner Series

Shifting the Treatment Paradigm of Weight Management and T2D in Primary Care & Managing Elevated LDL-C Levels to Reduce ASCVD Risk: Primary and Secondary Prevention

Join us for two interactive presentations where leading experts will provide insight on management of elevated LDL-C levels to reduce ASCVD risk in the primary care setting and updates to weight management recommendations in patients with type 2 diabetes.

  AAPA
  | AMA
  | ANCC
Who Should Attend

US primary care physicians, nurse practitioners (NPs), physician associates/physician assistants (PAs)

All Events

Managing Elevated LDL-C Levels to Reduce ASCVD Risk: Primary and Secondary Prevention & Shifting the Treatment Paradigm of Weight Management and T2D in Primary Care

Past Events

July

25

2023

4:30 PM - 6:45 PM Central Time (CT)

Virtual

Faculty

ProCE Banner Faculty
Martin J. Abrahamson, MD, FACP

Associate Professor of Medicine
Harvard Medical School
Director, Division of CME
Beth Israel Deaconess Medical Center
Boston, Massachusetts

ProCE Banner Faculty
Leslie Eiland, MD

Assistant Professor
Division of Diabetes, Endocrinology & Metabolism
University of Nebraska Medical Center
Omaha, Nebraska

ProCE Banner Faculty
Ty Gluckman, MD, MHA, FACC, FAHA, FASPC

Medical Director, Center for Cardiovascular Analytics, Research and Data Science (CARDS) Providence Heart Institute
Providence St. Joseph Health
Portland, Oregon

ProCE Banner Faculty
Viet Le, DMSc, PA-C, FACC, FAHA, HF-Cert

Associate Professor of Research, Preventive Cardiology PA
Intermountain Heart and Vascular Clinical Program
Intermountain Health, Canyons Region
Salt Lake City, Utah

Topics

4:30 – 5:30 PM CT Managing Elevated LDL-C Levels to Reduce ASCVD Risk: Primary and Secondary Prevention
5:30 – 5:45 PM CT Break
5:45 – 6:45 PM CT Shifting the Treatment Paradigm of Weight Management and T2D in Primary Care

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Shifting the Treatment Paradigm of Weight Management and T2D in Primary Care:

Goal Statement
To improve the knowledge, competence, and performance of primary care physicians, NPs, and PAs in application of evidence-based practices to optimize early treatment for patients with T2D and overweight/obesity to improve long-term outcomes.

Target Audience
US primary care physicians, nurse practitioners (NPs), physician associates/physician assistants (PAs)

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Modify treatment regimens according to the latest evidence and guideline recommendations that reflect the importance of early therapy intensification to meet individualized needs of patients with T2D
  • Select the most appropriate incretin-based therapies for the treatment of patients with overweight or obesity and T2D
  • Apply patient-centered strategies that address sustained weight loss as a primary treatment target for T2D

 

Managing Elevated LDL-C Levels to Reduce ASCVD Risk: Primary and Secondary Prevention:

Program Overview
Join us for an interactive presentation where leading experts provide insight on management of elevated LDL-C levels to reduce ASCVD risk in the primary care setting. Learn about guideline recommendations and treatment options, including non-statin therapies.

Goal Statement
The goal of this program is to improve the knowledge and competence of primary care clinicians who manage patients with elevated LDL-C levels to reduce ASCVD risk.

Target Audience
The intended audience for this educational initiative is primary care clinicians who are responsible for identifying patients that would benefit from LDL-C lowering and for initiating and intensifying primary and secondary prevention.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Assess the efficacy, safety, and mechanism of action of non-statin agents approved to manage LDL-C levels.
  • Devise individualized evidence-based primary prevention plans for patients with elevated LDL-C levels.
  • Develop personalized strategies for secondary prevention for patients with elevated LDL-C levels using evidence-based guidelines.
  • Escalate treatment of elevated LDL-C levels by incorporating approved non-statin agents when statins alone do not achieve 2018 blood cholesterol guideline goals.

Accreditation

Shifting the Treatment Paradigm of Weight Management and T2D in Primary Care:

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 2.0 contact hours.

Physician Assistant/Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

 

Managing Elevated LDL-C Levels to Reduce ASCVD Risk: Primary and Secondary Prevention:

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of USF Health and Rockpointe. USF Health is accredited by the ACCME to provide continuing medical education for physicians.

Physician Continuing Medical Education

Designation of Credit

USF Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

This activity is approved for 1.0 contact hour(s) of continuing education (which includes 1.0 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 23036015. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Physician Assistant/Physician Associate Continuing Medical Education

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 4/4/2023 to 9/4/2024. AAPA reference number: CME-209116.

American Board of Internal Medicine Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC point and patient safety MOC credit in the American Board of Internal Medicine's (ABIM’s) Maintenance of Certification (MOC) program. It is USF Health’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participants will earn MOC Points equivalent to the amount of CME credits claimed for the activity. USF Health will submit within 60 days the Diplomat’s MOC Points. No ABIM MOC Points certificates will be provided. Diplomats with questions regarding their Points, should contact USF Health at cpdsupport@usf.edu.

To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through USF Health's ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

AAFP Credit Designation Statement
The AAFP has reviewed Managing Elevated LDL-C Levels to Reduce ASCVD Risk: Primary and Secondary Prevention, and deemed it acceptable for AAFP credit. Term of approval is from 04/04/2023 to 08/01/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).

Disclosure of Conflicts of Interest 
USF Health adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant financial relationships are listed below. All individuals not listed have no relevant financial relationships.

Acknowledgement

Shifting the Treatment Paradigm of Weight Management and T2D in Primary Care:

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange.

This activity is supported by educational grants from Lilly and Novartis.

 

Managing Elevated LDL-C Levels to Reduce ASCVD Risk: Primary and Secondary Prevention:

Jointly provided by USF Health and Rockpointe, in partnership with Clinical Care Options, LLC.

Supported by an educational grant from Novartis Pharmaceuticals Corporation.